Article

BRCA1/2 Mutation Testing Among Adult Women With HER2-Negative Advanced Breast Cancer: Results From a Multi-Country, Real-World Study

2021-07-08

Abstract excerpt

<title>Abstract</title> <p><italic>Purpose:</italic> We assessed real-world patient demographics and <italic>breast cancer susceptibility genes</italic> <italic>1 or 2 </italic>(<italic>BRCA1/2</italic>) mutation testing rates among adult women with human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (ABC). <italic>Methods:</italic> Oncologists across the US and EU5 abstracted data fro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0ebe31d8-0e3c-514b-932c-c7a37df4d7c0
DOI: 10.21203/rs.3.rs-682449/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

BRCA1/2 Mutation Testing Among Adult Women With HER2-Negative Advanced Breast Cancer: Results From a Multi-Country, Real-World StudyDOI 10.21203/rs.3.rs-682449/v1Read

Real-world multi-country study of BRCA1/2 mutation testing among adult women with HER2-negative advanced breast cancer.Semantic proximity Read

Real-World Study of Regional Differences in Patient Demographics, Clinical Characteristics, and BRCA1/2 Mutation Testing in Patients with Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the United States, Europe, and Israel.Semantic proximity Read

Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.Semantic proximity Read

Genetic testing in women with breast cancer: implications for treatment.Semantic proximity Read

Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.Semantic proximity Read

Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer–Real-World Data from Two Large German Breast CentersSemantic proximity Read

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer PatientsSemantic proximity Read

Clinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer.Semantic proximity Read

<em>BRCA1/2</em> Testing Landscape in Ovarian Cancer: A Nationwide, Real-World Data StudySemantic proximity Read

Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutationsSemantic proximity Read

BRCA testing and Japanese original testing criteria for hereditary breast and ovarian cancer covered by public health insuranceSemantic proximity Read

Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practiceSemantic proximity Read